Lopinavir Population Pharmacokinetics in HIV-infected Patients from Resource-limited Settings Receiving Second-line Treatment with Lopinavir/Ritonavir Monotherapy in AIDS Clinical Trials Group (ACTG) Study 5230
Publication
, Conference
Vezina, HE; Park, J-G; Wallis, CL; Bartlett, JA; Kumarasamy, N; Stevens, WS; Klingman, KL; Ribaudo, HJ; Katzenstein, DA
Published in: JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
May 1, 2013
Duke Scholars
Published In
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
EISSN
1573-8744
ISSN
1567-567X
Publication Date
May 1, 2013
Volume
40
Start / End Page
S31 / S32
Publisher
SPRINGER/PLENUM PUBLISHERS
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Vezina, H. E., Park, J.-G., Wallis, C. L., Bartlett, J. A., Kumarasamy, N., Stevens, W. S., … Katzenstein, D. A. (2013). Lopinavir Population Pharmacokinetics in HIV-infected Patients from Resource-limited Settings Receiving Second-line Treatment with Lopinavir/Ritonavir Monotherapy in AIDS Clinical Trials Group (ACTG) Study 5230. In JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (Vol. 40, pp. S31–S32). SPRINGER/PLENUM PUBLISHERS.
Vezina, Heather E., Jeong-Gun Park, Carole L. Wallis, John A. Bartlett, Nagalingeswaran Kumarasamy, Wendy S. Stevens, Karin L. Klingman, Heather J. Ribaudo, and David A. Katzenstein. “Lopinavir Population Pharmacokinetics in HIV-infected Patients from Resource-limited Settings Receiving Second-line Treatment with Lopinavir/Ritonavir Monotherapy in AIDS Clinical Trials Group (ACTG) Study 5230.” In JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 40:S31–32. SPRINGER/PLENUM PUBLISHERS, 2013.
Vezina HE, Park J-G, Wallis CL, Bartlett JA, Kumarasamy N, Stevens WS, et al. Lopinavir Population Pharmacokinetics in HIV-infected Patients from Resource-limited Settings Receiving Second-line Treatment with Lopinavir/Ritonavir Monotherapy in AIDS Clinical Trials Group (ACTG) Study 5230. In: JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS. SPRINGER/PLENUM PUBLISHERS; 2013. p. S31–2.
Vezina, Heather E., et al. “Lopinavir Population Pharmacokinetics in HIV-infected Patients from Resource-limited Settings Receiving Second-line Treatment with Lopinavir/Ritonavir Monotherapy in AIDS Clinical Trials Group (ACTG) Study 5230.” JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, vol. 40, SPRINGER/PLENUM PUBLISHERS, 2013, pp. S31–32.
Vezina HE, Park J-G, Wallis CL, Bartlett JA, Kumarasamy N, Stevens WS, Klingman KL, Ribaudo HJ, Katzenstein DA. Lopinavir Population Pharmacokinetics in HIV-infected Patients from Resource-limited Settings Receiving Second-line Treatment with Lopinavir/Ritonavir Monotherapy in AIDS Clinical Trials Group (ACTG) Study 5230. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS. SPRINGER/PLENUM PUBLISHERS; 2013. p. S31–S32.
Published In
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
EISSN
1573-8744
ISSN
1567-567X
Publication Date
May 1, 2013
Volume
40
Start / End Page
S31 / S32
Publisher
SPRINGER/PLENUM PUBLISHERS
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences